PharVision Advisers’s Lithium Americas LAC Stock Holding History
Bought
Maintained
Sold
Other funds holding LAC
PharVision Advisers's LAC Position: Q3 2026 in Review
PharVision Advisers opened a new position in Lithium Americas (LAC) in Q3 2026: 11,758 shares worth $30.9K. The stake represents 1.26% of the portfolio and ranks #27 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in LAC as recently as Q3 2025.
PharVision Advisers first reported a position in LAC in Q3 2025 and has held it in 2 quarters since. The position peaked at $169K in Q3 2025. 119 funds tracked by Wall St. Rank hold LAC as of Q3 2026.
- PharVision Advisers held 11,758 shares of Lithium Americas worth $30.9K as of Q3 2026.
- Lithium Americas was a new PharVision Advisers position in Q3 2026.
- Lithium Americas made up 1.26% of PharVision Advisers's portfolio in Q3 2026, its #27 holding.
- PharVision Advisers first reported a position in Lithium Americas in Q3 2025 and has held it in 2 quarters since.
- PharVision Advisers's Lithium Americas position peaked at $169K in Q3 2025.
- 119 funds tracked by Wall St. Rank held Lithium Americas as of Q3 2026.
Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.